booksshare.net -> -> -> .. -> " " -> 165

- ..

.. , 1962. 711 c.
( ): pharmazeutischewirkstoffe1982.djvu
<< 1 .. 159 160 161 162 163 164 < 165 > 166 167 168 169 170 171 .. 345 >>

5,16-pregnadien
(aus Dehydropregnenolon, analog a)
1 L1/NH3
2 снэ:
2. Methyl-* jodid
-CH3
1 Oppenauer-Oxidation Cl Cl
2. 0=<^t=0 Cl Cl
Medrogeston
546 M Medrogeston - Medroxyprogesteronacetat
a USP3 133 913 (American Home Products, ert. 19.5.1964; Anm. 11.9.1961).
R. Deghenghi, R. Gaudry, J. Am. Chem. Soc. 83,4668 (1961).
Ausgangsverbindung:
P. A. Plattner et al., Helv. Chim. Acta 31,603 (1948). b R. Deghenghi et al., J. Med. Chem. 6,301 (1963).
Ausgangsverbindung:
D. Bum et al., J. Chem. Soc. 1957,4092.
Weitere Verfahren:
USP 3 170 936 (American Home Products; ert. 23.2.1965; Anm. 7.8.1963).
USP 3 210387 (American Home Products; ert. 5.10.1965; Anm. 6.5.1963; CDN-Prior. 28.11.1962).
D: Prothil® (Kali-Chemie) I: Colpro® (Ayerst)
F: Colprone® (Auclair) USA: Colprone® (Ayerst)
Medroxyprogesteron- 71-58-9 Gestagen acetat
17a-hydroxy-6a-methylpregn-4-ene-3,20-dione-acetate
a
0
CH3
HCl/CHCl;
0
fH3C—COhO/CHKOOH/tTos—OH
Acetanhydrid
5а, 17а-0«у(1гоху-3,20-
dioxo-60-methyl-5a-
pregnan
17a-Hydroxy-6a-methyl-
progesteron (Medroxyprogesteron)
CH3
b
Glykol
Medroxyprogesteronacetat - Medrylamin M 547
CH
Perbenzoesaure
CH3MgBr
Methylmagnesiu
bromid
17a-Hydroxy-5a-methyl-
progesteron
(Medroxyprogesieron)
(НэС-С0]20/[Т05-0Н]
Medroxyproges1eron-17or-acetat
DOT 4, 14(1968).
a USP 3 147 290 (Upjohn; ert. 1.9.1964; Anm. 17.5.1961; Prior. 23.11.1956).
B. Ellis et al.. J. Chem. Soc. 1957,4092.
Ausgangsverbindung: Zitat a b USP 3 061616 (Societa Farmaceutici Italia; ert. 30.10.1962; Anm. 17.9.1958; GB-Prior. 24.4.1958). DBP 1 097 986 (Syntex; Anm. 29.8.1957; MEX-Prior. 8.9.1956).
J. C. Babcock et al., J. Am. Chem. Soc. 80,2904 (1958).
Ausgangsverbindung:
S. Bernstein et al., J. Am. Chem. Soc. 76,5674 (1954).
The Merck Index, 4756 (Rahway 1976).
Weitere Verfahren:
DBP 1 081456 (British Drug Houses; Anm. 21.8.1958; GB-Prior. 13.8.1957).
DBP 1101415 (Searle; Anm. 24.9.1958; USA-Prior. 27.9.1957).
USP 3 043 832 (Ormonoterapia Richter; ert. 10.7.1962; Anm. 28.4.1961; I-Prior. 27.2.1961). Obersicht:
Ehrhardt, Ruschig III, 352.
D: Clinovir® (Upjohn)
Depo-Clinovir® (Upjohn)
Farlutal® (Montedison Pharma) Niagestin® (Novo)
F: Depo-Prodasone® (Upjohn)-Komb. Farlutal® (Specia)
Prodasone® (Upjohn)
GB: Depo-Provera® (Upjohn)
Provera® (Upjohn)
I: Depo-Provera® (Upjohn)
Farlutal® (Farmitalia)
Luteocrin® (Richter)
Luteodione® (Panther-Osta Chemie) Luteos® (Ion)
Lutoral® (Midy)
Metilgestene® (Farmila)
J; Hysron® (Kyowa)
Provera® (Upjohn)
USA: Amen® (Camrick)
Curretab® (Reid-Provident)
Cytran® (Upjohn)-Komb.
dep Coriutin (O’Neal, Jones & Feldman)
Depo-Provera® (Upjohn)
P-Medrate® (Tutag)
Provera® (Upjohn)
Medrylamin 524-99-2 Antihistaminicum
6027-00-5 Hydrochlorid
2-(p-methoxy-a-phenylbenzyloxy)-;V,N-dimethyIethylamine
H3C0 H3C0
li CH3 li
\ / NaOH \
CH-Ct + ho-ch2-ch2-n -► С
4-Methoxy- 2-0tmethylamino- Medrylamin
benzhydryl- ethanol
chlorid
548 M Medrylamin - Medryson - Mefenamsaure
USP 2 668 856 (UCB; ert. 1954; Anm. 1948).
D: Corti-Postafen® (UCB)-Komb. Postafen® Salbe (UCB)
Medryson 2668-66-8 Gestagen
1 l/?-hydroxy-6a-methyipregna-4-ene-3,20-dione
H3CN ^0 1 9" 1. но-сч2-сн2—0H/[H3C-<fy— so3h] tTTtn 2- LiAlH‘/THF л 117 1 / 3. H2SO4/CH3OH Г T Й|Й '• Ethylen9lyko1 ^ p-Toiuolsuilonsaure Uthiumalanat H3C H°V/JJ
CH3 CH3
60- Methyl -11 -oxoprogesteron Medryson
USP 2 864 837 (Upjohn; ert. 1958; Prior. 1958). USP 2 968 655 (Upjohn; ert. 1961; Prior. 1956). Ausgangsverbindung: G. B. Spero et al., J. Am. Chem. Soc. 78,6213 (1956). USP 2 968 655 (Upjohn; ert. 1961; Prior. 1956).
D: Ophtocortin® (Winzer) Oftisone® (Sidus)-Komb. Spectramedryn® (Allergan) Visudrisone® (Italseber) F: Medryson Faure (Lab. Faure) USA: HMS® Liquifilm® (Allergan) I: Ipoflogin® (Tubi Lux) Medrocort® (Upjohn) Medrifar® (Farmitalia)
Mefenamsaure
(Mefenamic acid)
61-68-7
Antiphlogisticum;
Antirheumaticum;
Analgeticum
W-(2,3-xylyl)anthranilic add
COO K* 1H.C-C0-C)2-J
gr уУ KupfwdD-acetat
H3C CH3
2-Brombenzoe- 2,3-Dimethyl-
saure(Kalium-Salz) amlin
DOT 1,59 (1965).
USP 3 138 636 (Parke-Davis; ert. 23.6.1964; Anm. 23.6.1960).
DBP 1 163 846 (Parke-Davis; Anm. 22.6.1961; USA-Prior. 23.6.1960). Weitere Verfahren:
DAS 1186 073 (Parke-Davis; Anm. 30.4.1963; CDN-Prior. 18.9.1962). DAS 1 186074 (Parke-Davis; Anm. 30.4.1963; CDN-Prior. 18.9.1962). DAS 1 186870(Parke-Davis; Anm. 30.4.1963;CDN-Prior. 18.9.1962). DAS 1 186871 (Parke-Davis; Anm. 30.4.1963; CDN-Prior. 18.9.1962).
COOH NH-H3C CH3 Mefenamsaure
-Q
. Mefenamsaure - Melenorex - Mefexamid M 549
D: Parkemed® (Parke-Davis) Parke-Med® (Parke Davis)
Ponalar® (Parke-Davis) J: Baphameritin M® (Hishiyama)
F: Ponstyt® (Parke-Davis) Bonabol® (Sawai)
GB: Ponstan® (Parke-Davis) Pontal® (Parke-Davis-Sankyo)
I: Lysalgo® (Schiapparelli) Spantac® (Uji)
Metedolo® (Ion) USA: Ponstei® (Parke-Davis)
Mefenorex 17243-57-1 Appetitzugler
<< 1 .. 159 160 161 162 163 164 < 165 > 166 167 168 169 170 171 .. 345 >>

c1c0fc952cf0704ad12d6af2ad3bf47e03017fed

, ?
2009 BooksShare.
.
Rambler's Top100

c1c0fc952cf0704ad12d6af2ad3bf47e03017fed